Drug intelligence / Profile preview

Folltropin-V

Development stage
Unknown
Lead developer
Vetoquinol
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

**Folltropin-V** is a highly purified, porcine pituitary-derived follicle stimulating hormone (FSH) preparation for veterinary use in cattle. It is supplied as a lyophilized powder (700 IU per vial, equivalent to 400 mg NIH-FSH-P1 standard) reconstituted with bacteriostatic sodium chloride diluent for intramuscular injection, delivering 35 IU/mL. Developed and marketed by Vétoquinol, it is FDA-approved exclusively for inducing superovulation in reproductively mature beef and dairy heifers and cows to facilitate embryo transfer programs, administered as 87.5 IU twice daily for 4 days starting days 8-10 post-estrus, combined with prostaglandin for luteolysis. It exhibits a short half-life (~4-5 hours), rapid absorption, and targets ovarian follicles without systemic toxicity beyond reproductive organs.[1][3][9][11]

Brand names
Folltropin-VFOLLTROPIN
Other names
Folltropin
02

Targets

FSHR (Follicle-stimulating hormone receptor)

Beyond the preview

Go deeper on Folltropin-V.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folltropin-V.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call